UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6K
REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 AND 15d -16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 1998
NATIONAL HEALTHCARE MANUFACTURING CORPORATION
(Name of Registrant)
251 Saulteaux Crescent, Winnipeg, Manitoba Canada R3J 3C7
(Address of principal executive offices)
1. News Release March 18, 1998
Indicate by check mark whether the Registrant files of will file annual
reports under cover of Form 20-F of Form 40-F.
Form 20-F X Form 40-F ___
Indicate by check mark whether the Registrant by furnishing the information
contained in this form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934. Yes ___ No X
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1943 , the
registrant has duly cause this Form 6-K to be signed on its behalf by the
undersigned, thereunto duly authorized.
National Healthcare Manufacturing Corporation -- SEC No. 0-27998
(Registrant)
Date: April 6, 1998 By:/s/M. Seyed Torabian
------------------------------
M. Seyed Torabian,
Vice President/Director
<PAGE>
National Healthcare Manufacturing Corp. Simplex Medical Systems Inc.
(NASDAQ: NHMCF/VSE:NHM) (OTC BB: SMLX)
251 Saulteaux Crescent 430 Ansin Blvd., Suite G
Winnipeg, MB R3J 3C7 Hallandale, FL 33009
Contact: Alex P. Tsakumis Contact: Henry B. Schur
(800)883-8841 / (604)689-8337 (954)455-0110 / (954)455-9008
Internet: www.nationalhealthcare.com
EXCLUSIVE SUPPLY / PURCHASE AGREEMENT
March 18, 1998 - National Healthcare Manufacturing Corporation (NHMC) and
Simplex Medical Systems Inc. (SMS) are pleased to announce signing a long
term supply/purchase agreement. NHMC's manufacturing facility in Antioch,
Illinois, will exclusively package, in one of its patented delivery
systems, all of the buffer solution manufactured and used in SMS's unique
HIV Diagnostic Test Kit. Production of the test kits using the new buffer
will start April 1st, 1998. SMS will introduce the new test kits into its
manufacturing, sales and marketing program immediately thereafter.
In addition, NHMC and SMS have begun negotiations on developing and
manufacturing the next generation test kit which will incorporate the
advanced packaging concepts of NHMC into a fully integrated, user friendly
line of rapid, saliva-based point-of-use testing systems which SMS will
distribute throughout its distribution network.
SMS is engaged in the development, manufacturing, acquisition and marketing
of a variety of products in the medical and dental industry. All of SMS's
products are manufactured in the United States in FDA registered
facilities. Some of the Company's products are currently approved for sale
in Venezuela, Spain, Costa Rica and other countries around the world.
Ongoing registrations are in progress in China, Europe and India.
Darrell Van Dyke, Vice President of NHMC stated, We are very pleased to
have this relationship with the most innovative company in the HIV
Diagnostic Test Kit marketplace. This agreement lends significant
credibility to the use of our unique patented liquid/powder delivery
systems in various venues of the medical industry.
Tom Glickman, Vice President of Marketing for SMS commented that, This
association with a proven innovator and leader in the medical packaging
field will enable SMS to rapidly move forward to advance its R&D efforts to
bring new and valuable diagnostic tools to the medical community.
This agreement provides NHMC with an immediate presence in the ever growing
$1 billion diagnostic kit industry.
NHMC is rapidly emerging as a market leader whose mission is to bring about
cost reduction in the healthcare industry by providing a comprehensive
array of innovative products and services that incorporate unique products,
custom packaging, along with the state of the art supply management
distribution technology.
On Behalf of the Board (NHMC), On Behalf of the Board (SMS),
/s/M. Seyed Torabian /s/ Nicholas Levandoski
- ------------------------- --------------------------
M. Seyed Torabian, P.Eng. Nicholas Levandoski
Executive Vice President President
Neither NASDAQ nor the VSE have reviewed or accept responsibility for the
accuracy of this release.
